Mariner
ORGO icon

Mariner’s Organogenesis Holdings ORGO Stock Holding History

Mariner’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Buy
147,731
+122,745
+491% +$300K ﹤0.01% 2698
2026
Q1 		$59.2K Buy
24,986
+1,819
+8% +$6.3K ﹤0.01% 3407
2025
Q4 		$120K Sell
23,167
-13,795
-37% -$66.8K ﹤0.01% 3295
2025
Q3 		$156K Sell
36,962
-10,556
-22% -$49.1K ﹤0.01% 3260
2025
Q2 		$174K Buy
47,518
+7,824
+20% +$29.2K ﹤0.01% 3098
2025
Q1 		$171K Buy
39,694
+1,353
+4% +$5.46K ﹤0.01% 3053
2024
Q4 		$123K Buy
+38,341
New +$129K ﹤0.01% 3136

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mariner's ORGO Position: Q2 2026 in Review

Mariner increased its Organogenesis Holdings (ORGO) stake by 491% in Q2 2026, buying an estimated $300K and bringing the position to 147,731 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

Mariner first reported a position in ORGO in Q4 2024 and has held it in 7 quarters since. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Mariner held 147,731 shares of Organogenesis Holdings worth $359K as of Q2 2026.
  • Mariner bought 122,745 Organogenesis Holdings shares in Q2 2026, an estimated $300K.
  • Organogenesis Holdings made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2698 holding.
  • Mariner first reported a position in Organogenesis Holdings in Q4 2024 and has held it in 7 quarters since.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.